Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35266965.
- Also identified by DOI 10.1001/jamaoncol.2022.0070 and PMC identifier 8914887.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This case series describes the use of early intrathecal steroid administration to manage high-grade and steroid-refractory immune effector cell-associated neurotoxicity syndrome among patients with B-cell non-Hodgkin lymphoma.
Medical subject headings
- Neurotoxicity Syndromes
- Receptors, Chimeric Antigen